Results 61 to 70 of about 19,741 (164)

Correction: Enhancing post-operative hypothyroidism treatment: rat thyroid autotransplantation into a pre-vascularized, retrievable cell pouch™ device. [PDF]

Front Endocrinol (Lausanne)
Memarnejadian A, Pakshir P, Tomlinson M, Berjisian F, Dortas Maffei L, Winhall M, Muirhead B, Mofford J, Sheardown H, Ataei Mehr B, Parikh V, Shannon FR, Calias P, Toleikis PM.   +13 more
europepmc   +1 more source

98 ATA3271: an armored, next-generation off-the-shelf, allogeneic, mesothelin-CAR T cell therapy for solid tumors

Journal for ImmunoTherapy of Cancer, 2020
Alfonso Brito, Yannick Bulliard, Jiangyue Liu, Xianhui Chen, Jason Karlen, Tiffany Jheng, Philippe Foubert, Janani Krishnamurthy, Blake Aftab   +8 more
doaj   +1 more source

334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors

Journal for ImmunoTherapy of Cancer, 2023
Paul Rennert, Lihe Su, Lan Wu, Roy Lobb, Christine Ambrose   +4 more
doaj   +1 more source

Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer. [PDF]

JCO Precis Oncol
Wijetunga NA, Mankuzhy NP, Lebow ES, Boe LA, Pike LRG, Schoenfeld AJ, Shaverdian N, Chaunzwa TL, Jones DR, Chaft JE, Rudin CM, Kris MG, Yu HA, Chang JC, Iyengar P, Gomez DR.   +15 more
europepmc   +1 more source

Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain. [PDF]

Fluids Barriers CNS
Gampa G, Vadlakonda R, Stefanich E, Kamath AV, Sadekar S, Shivva V.   +5 more
europepmc   +1 more source

1535 DECOSTARTM, a novel platform for TNF receptor superfamily agonism

Journal for ImmunoTherapy of Cancer, 2023
Rakesh Verma, Dulce Alvarado, Wojciech Bartkowski, Mickey Pentecost   +3 more
doaj   +1 more source

Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation. [PDF]

J Med Chem
Hopkins BT, Marx IE, Vandeveer HG, Nevalainen M, Basile R, Bajrami B, Choi CK, Grater RJ, Gu C, Hoemberger M, Kadakia E, Kapadnis SK, Liu Y, Ma B, Magee T, Metrick CM, Mingueneau M, Muste CA, Parker Harp CR, Prince RJ, Santoro JC, Schulz J, Sciabola S, Tang H, Wang T, Meissner R, Bohnert T.   +26 more
europepmc   +1 more source

A tri-specific EGFR/cMet/VEGF antibody demonstrates potent multi-mechanistic activity in preclinical triple-negative breast cancer models. [PDF]

J Biol Chem
Pu P, Jin Y, Zhang S, Xu Y, Chen P, Zhou F, Sun P, Jiang H, Huang S, Chen L, Fu M, Zha Z, MacWilliams MP, Chiu ML.   +13 more
europepmc   +1 more source

Atara Biotherapeutics [PDF]

, 2020
openaire   +1 more source

1048 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that reduces CD8+ T cell exhaustion to induce potent antitumor activity

Journal for ImmunoTherapy of Cancer, 2023
Ivana Djuretic, Yik Andy Yeung, Renee Greer, Arisa Paul, Jeffrey Houser, Audrey Hollingsworth, Wei Wei Prior, Manu Kumar, Ruth Lan   +8 more
doaj   +1 more source